DIN 02554313 — FABHALTA 200 MG
FABHALTA is a capsule of Iptacopan marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Iptacopan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02554313
- Brand name
- FABHALTA
- Active ingredient
- Iptacopan
- Strength
- 200 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Complement factor B inhibitor (alternative pathway complement inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.